コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 hts into cell division with implications for cancer research.
2 ase, but it also has particular relevance to cancer research.
3 ntegrated platform to accelerate PRS-related cancer research.
4 ciated biomarkers can help drive advances in cancer research.
5 to derive mechanistic hypotheses for future cancer research.
6 milar problems but has been underutilized in cancer research.
7 function are, nowadays, attractive goals in cancer research.
8 ate the performance of new therapies in lung cancer research.
9 y of Flura-seq are broadly applicable beyond cancer research.
10 me in Southern California and to continue in cancer research.
11 c, NCI's priority remains the advancement of cancer research.
12 ng RAS remains a highly sought-after goal of cancer research.
13 alterations (CNAs) has broad applications in cancer research.
14 ational Health Service, and the Institute of Cancer Research.
15 ome, thereby providing copious resources for cancer research.
16 nized as one of the central issues in breast cancer research.
17 s in inflammation, environmental-stress, and cancer research.
18 umor viruses, both of which are important in cancer research.
19 inistration policies will have on successful cancer research.
20 evaluate the utility of them for metastatic cancer research.
21 ation of differentially methylated genes for cancer research.
22 ificant contributions to the field of kidney cancer research.
23 , which are molecules of growing interest in cancer research.
24 t, significant efforts are being invested in cancer research.
25 in tumour progression is at the forefront of cancer research.
26 nce these data toward mainstream adoption in cancer research.
27 ry, developmental biology, neuroscience, and cancer research.
28 MicroRNAs (miRNAs) hold great promise in cancer research.
29 rgence of resistance is a major challenge in cancer research.
30 pathways has been placed in the forefront of cancer research.
31 ifferent areas, namely leukemia and melanoma cancer research.
32 immune evasion and the future prospects for cancer research.
33 or improving reproducibility in pre-clinical cancer research.
34 icals are used often in vitro and in vivo in cancer research.
35 tal benchmark for immunogenomics analyses in cancer research.
36 m FA research serves basic and translational cancer research.
37 evelopmental biology as well as stem cell or cancer research.
38 ification has long been an important task in cancer research.
39 hanistic insights that are useful for future cancer research.
40 ly facilitate application of NGS in clinical cancer research.
41 iew, knowledge discovery and applications in cancer research.
42 to explore cellular behavior and facilitate cancer research.
43 ultiple essential questions in translational cancer research.
44 chemotherapy has remained an elusive goal in cancer research.
45 ding questions for future basic and clinical cancer research.
46 nstitutes of Health, and Hope Foundation for Cancer Research.
47 ciences are often overlooked in the field of cancer research.
48 have made them a major field of interest in cancer research.
49 enetically engineered mouse models (GEMM) in cancer research.
50 ute of Oncology, and Italian Association for Cancer Research.
51 d diseases and may offer novel insights into cancer research.
52 EGFR tyrosine kinase-an important target in cancer research.
53 of cancer care, and the severe disruption to cancer research.
54 increased consideration of sex in molecular cancer research.
55 ogy studies, vaccine trials, and HPV-related cancer research.
56 basic science and clinical aspects of breast cancer research.
57 ssociated Charities, AbbVie, and Gateway for Cancer Research.
58 p53 in many areas of basic and translational cancer research.
59 lighted as one of the important topics among cancer researches.
60 form of vitamin D, has been applied in anti-cancer researches.
62 blic and philanthropic funding for childhood cancer research-a proxy for global research activity-to
63 his award who work in fields associated with cancer research about their views on good mentoring, and
64 ncer Dream Team (Stand Up To Cancer, Ovarian Cancer Research Alliance, National Ovarian Cancer Coalit
65 o models have led to significant advances in cancer research, allowing the investigation of cells in
68 executable models have impacted the field of cancer research and argue that extending them to represe
70 mathematics, chemistry, and engineering with cancer research and clinical oncology through education,
71 rstanding the role of IL-6 in the context of cancer research and COVID-19 and suggest how lessons lea
74 sequencing (SCS) has impacted many areas of cancer research and improved our understanding of intrat
75 w spans many of the most active paradigms in cancer research and includes agents that target cancer-r
77 d driver mutations is critical for advancing cancer research and personalizing treatment based on acc
78 Immuno-oncology is an innovative area of cancer research and practice that seeks to help the pati
80 ncestry and diversity of cellular models for cancer research and present an interactive tool, Estimat
81 tionale for the use of research autopsies in cancer research and provide an evidence-based discussion
82 -signaling pathway is an important target in cancer research and regenerative medicine; yet, on the c
84 re of the meeting, a coalition of pancreatic cancer research and support foundations participated, wi
86 s the immense contributions of immigrants to cancer research and the adverse impact that current admi
87 l, developed by the Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group, compared
89 role for MP in extracorporeal liver support, cancer research and therapeutics, and pharmaceutical tes
91 His profound legacy on targeted therapy and cancer research and treatment continue to prolong and sa
92 HVEPs represent a substantial advancement in cancer research, and continued improvement and implement
93 ividual driver mutations are central aims of cancer research, and have elucidated myriad phenotypes(5
97 low of tumorous lung analyses in preclinical cancer research as a strategy to obtain a more accurate
98 cancer care due to its deleterious effect on cancer research, as well as biological insights from the
99 few of the issues surrounding gender bias in cancer research, as well as science more generally, and
100 ntre and The Royal Marsden and Institute for Cancer Research Biomedical Research Centre and is coordi
101 udy by Zhao and colleagues, in this issue of Cancer Research, builds on previous work where they show
102 combinase technology are important tools for cancer research but can be costly and time-consuming.
104 tumor cells (CTCs) are of great interest in cancer research, but methods for their enumeration remai
105 Cultured cell lines are the workhorse of cancer research, but the extent to which they recapitula
106 ncer are mimicked in basic and translational cancer research by a steadily increasing number of tumor
107 R systems have enabled important advances in cancer research by accelerating the development of study
108 network-oriented communities of interest in cancer research by adapting methods from academic publis
109 early 1900s, the landmark article in 1978 in Cancer Research by Dougherty and his colleagues at the R
110 cer Genome Atlas (TCGA) has greatly advanced cancer research by generating, curating and publicly rel
111 ality and cost came from the Fred Hutchinson Cancer Research Center Food-Frequency Questionnaire link
112 n, University of Liverpool, Spanish National Cancer Research Center, Cambridge University Hospital, a
117 ears, and three challenges to the pancreatic cancer research community as it moves toward to the goal
118 Here we discuss current challenges for the cancer research community as they apply to early career
119 ts support DNF as a valuable resource to the cancer research community by providing new hypotheses on
120 rch, as well as biological insights from the cancer research community that could help develop novel
121 This has spurred a massive effort by the cancer research community to identify mechanisms used by
122 ealth Promotion Foundation, Victorian Breast Cancer Research Consortium, Cancer Australia, National B
124 lyses, Davis and colleagues in this issue of Cancer Research define TAp63 and its downstream target m
126 tudy by Wang and colleagues in this issue of Cancer Research develops a deep learning algorithm with
127 two-dimensional (2D) culture models used in cancer research do not recapitulate aspects of the 3D tu
128 ction of well-characterised models for basic cancer research, drug-screening and personalised medicin
129 mouse models are increasingly being used in cancer research due to their increased clinical relevanc
136 of Health, National Cancer Institute, Breast Cancer Research Foundation, Australian National Health a
138 d Medical Research Council Australia, Breast Cancer Research Foundation, Sanofi Aventis, and AstraZen
140 talized cancer cell lines are widely used in cancer research, from mechanistic studies to drug screen
144 althcare Foundation (Ireland), Eccles Breast Cancer Research Fund, British Journal of Anaesthesia Int
151 s and is an important topic in translational cancer research, given its relevance in clinical oncolog
152 ma Research Foundation, Pershing Square Sohn Cancer Research grant, the PaineWebber Chair, Stand Up 2
153 merican College of Radiology Imaging Network Cancer Research Group A6702 multicenter trial helped con
159 intratumor heterogeneity, much attention in cancer research has focused on profiling heterogeneity o
164 integrated visual analytics tool for breast cancer research in general and for therapy stratificatio
167 eviously underappreciated area in pancreatic cancer research, influences the progression and therapeu
170 vitro, engineered surrogates in the field of cancer research is of interest for studies involving mec
176 ppressor genes RB1 and TP53 In this issue of Cancer Research, Li and colleagues demonstrate that prol
183 OVID-19 and suggest how lessons learned from cancer research may impact SARS-CoV-2 research and vice
185 entations given at the Irish Association for Cancer Research Meeting and importantly how the results
187 rk by Rafiei and colleagues in this issue of Cancer Research now supports this observation with genet
189 The integration of circadian biology into cancer research offers new options for making cancer tre
192 ic tomography, as described in this issue of Cancer Research, paves the way for tumor hypoxia studies
194 ported by the Department of Defense Prostate Cancer Research Program (W81XWH-14-2-0183, W81XWH-12-PCR
196 by Principe and colleagues in this issue of Cancer Research proposes a combinatorial approach based
197 se by Krysan and colleagues in this issue of Cancer Research provides an informative view of the proc
203 dy by Gonda and colleagues, in this issue of Cancer Research, represents the first combinatorial appr
204 ectively utilizing digital pathology data in cancer research requires the ability to manage, visualiz
213 is considered as the best in vitro model for cancer research (similar morphology, metabolite and oxyg
216 is important in areas including physiology, cancer research, stem-cell differentiation and drug disc
217 cations presented in this article is used in cancer research studies of morphologic characteristics o
219 rk by Murphy and colleagues in this issue of Cancer Research suggests that activation of the alternat
223 ORE (P50CA97186), the Institute for Prostate Cancer Research, the Veterans Affairs Research Program,
224 e of the greatest advances in the history of cancer research: the development of vaccines that preven
226 approach is impacting many diverse areas of cancer research, through review of the key presentations
229 convened in May 2016 by ASCO and Friends of Cancer Research to identify opportunities for when it wo
230 ays engaged in various forms of high-quality cancer research to optimize outcomes for their patients,
232 tlas (TCGA), there has been a major shift in cancer research to the use of data from aggregate cell p
233 l can be readily adopted in cell biology and cancer research to uncover, to our knowledge, novel driv
235 take an honest appraisal about the state of cancer research today, to debate "currently entrenched v
238 future experimental lung research including cancer research, transplantation, physiology, pharmacolo
240 7-1), Stand Up To Cancer (SU2C-AACR-DT0712), Cancer Research UK (CRM108X-A25144), and the UK Departme
241 zione AIRC per la Ricerca sul Cancro (AIRC); Cancer Research UK (CRUK); the Fundacion Cientifica de l
243 Cancer Immunology and Immunotherapy Centre, Cancer Research UK Birmingham Centre, University of Birm
245 cessfully treat patients with brain tumours, Cancer Research UK convened an international panel of cl
247 ildren's Charity, Olivia Hodson Cancer Fund, Cancer Research UK, and the National Institute of Health
253 e, Chugai, Pharmion, Celgene, Ortho Biotech, Cancer Research UK, Celgene, Merck Sharp & Dohme, and Am
254 Research Council, British Heart Foundation, Cancer Research UK, Economic and Social Research Council
256 undation of China, British Heart Foundation, Cancer Research UK, GlaxoSmithKline, Medical Research Co
257 Research Council, British Heart Foundation, Cancer Research UK, Kadoorie Charitable Foundation, Chin
258 Research Council, British Heart Foundation, Cancer Research UK, Kadoorie Charitable Foundation, Chin
265 coma Group, Swiss Paediatric Oncology Group, Cancer Research UK, National Institute for Health Resear
267 ormerly Leukaemia and Lymphoma Research) UK, Cancer Research UK, Sporting Chance Cancer Foundation, N
268 World Cancer Research Fund International, Cancer Research UK, Tehran University of Medical Science
278 Victoria; Cancer Institute New South Wales; Cancer Research UK; Danish Cancer Society; National Canc
279 ly, we highlight potential opportunities for cancer research using hPSC-derived organoids and genome
285 ng this period, global funding for childhood cancer research was US$2 billion, of which $772 million
286 l Conference of the American Association for Cancer Research, was held in Orlando, FL, on May 12 to 1
289 s have attempted to specialize hydrogels for cancer research; we comprehensively review this topic fo
290 ) have historically been at the forefront of cancer research, where they are known to act as critical
291 nomics has emerged as a valuable approach in cancer research, which integrates genomic and transcript
292 ing has enabled great advances to be made in cancer research with regards to diagnosis, prognosis, an
293 date has been concentrated predominantly on cancer research, with a relatively modest footprint in C
294 mune regulation has come to the forefront in cancer research, with myeloid-derived suppressor cells (